| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Comm &Corp Aff Officer | Director | Chief Commercial Officer
2 companies
Mercier Johanna serves as a Chief Comm &Corp Aff Officer at GILD and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 24 sells. Those positions are worth an estimated $18.6M at current prices.
Historically, Mercier Johanna's trades have earned a below-average insider score of 43/100 across 15 rated trades. Over a 12-month horizon, 12.5% of those trades were profitable, with an average 12-month return of -27.0%.
The biggest single holding is GILD (~$17.6M) as Chief Comm &Corp Aff Officer. The recent filings there lean toward selling, a net 179,098 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | GILD Gilead Sciences, Inc. | Chief Comm &Corp Aff Officer | Sell | 3,000 | $140.96 | $422,880.00 | -2.3% | -7.0% | - | |
| Dec 15, 2025 | GILD Gilead Sciences, Inc. | Chief Commercial Officer | Sell | 3,000 | $122.00 | $366,000.00 | -2.7% | +21.2% | - | |
| Nov 17, 2025 | GILD Gilead Sciences, Inc. | Chief Commercial Officer | Sale+OE | 28,000 | $125.86 | $3,524,173.42 | -11.4% | +25.1% | - | |
| Oct 15, 2025 | GILD Gilead Sciences, Inc. | Chief Commercial Officer | Sell | 3,000 | $118.08 | $354,240.00 | -2.7% | +2.9% | - | |
| Sep 15, 2025 | GILD Gilead Sciences, Inc. | Chief Commercial Officer | Sell | 3,000 | $113.57 | $340,710.00 | -2.6% | +6.4% | - | |
| Aug 15, 2025 | GILD Gilead Sciences, Inc. | Chief Commercial Officer | Sale+OE | 28,000 | $118.53 | $3,318,926.70 | -3.9% | +5.8% | - | |
| Jul 15, 2025 | GILD Gilead Sciences, Inc. | Chief Commercial Officer | Sell | 3,000 | $111.03 | $333,090.00 | -2.5% | +8.4% | +20.8% | |
| Jun 16, 2025 | GILD Gilead Sciences, Inc. | Chief Commercial Officer | Sell | 3,000 | $110.17 | $330,510.00 | -2.4% | +1.5% | +14.8% | |
| May 22, 2025 | GILD Gilead Sciences, Inc. | Chief Commercial Officer | Sale+OE | 28,000 | $107.52 | $3,010,563.60 | -7.0% | +11.2% | - | |
| Nov 6, 2024 | GILD Gilead Sciences, Inc. | Chief Commercial Officer | Sell | 5,000 | $91.28 | $456,400.00 | -6.4% | +6.9% | +34.6% |